From toxicity to immunity: Evaluating CAR-T and conventional therapies in multiple myeloma through quality-adjusted life year (QALY) outcomes

Guluzar Gulnur Itez, Asuman Sunguroğlu

Open source

DOI
10.1177/20406207261484713
Published
2026-09
Container
Therapeutic Advances in Hematology
Publisher
SAGE Publications
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/20406207261484713,
  title = {From toxicity to immunity: Evaluating CAR-T and conventional therapies in multiple myeloma through quality-adjusted life year (QALY) outcomes},
  author = {Guluzar Gulnur Itez and Asuman Sunguroğlu},
  year = {2026},
  journal = {Therapeutic Advances in Hematology},
  doi = {10.1177/20406207261484713},
  url = {https://doi.org/10.1177/20406207261484713}
}

RIS

TY  - JOUR
TI  - From toxicity to immunity: Evaluating CAR-T and conventional therapies in multiple myeloma through quality-adjusted life year (QALY) outcomes
AU  - Guluzar Gulnur Itez
AU  - Asuman Sunguroğlu
PY  - 2026
JO  - Therapeutic Advances in Hematology
DO  - 10.1177/20406207261484713
UR  - https://doi.org/10.1177/20406207261484713
ER  - 

APA

Itez, G. G., & Sunguroğlu, A. (2026). From toxicity to immunity: Evaluating CAR-T and conventional therapies in multiple myeloma through quality-adjusted life year (QALY) outcomes. Therapeutic Advances in Hematology. https://doi.org/10.1177/20406207261484713

Source records